Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001375247-10-000007
Filing Date
2010-03-15
Accepted
2010-03-12 20:36:53
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 OBAGI MEDICAL PRODUCTS 10K obagi200910k.htm 10-K 2064252
2 OMP PERFORMANCE AGREEMENTS performancegraph10k2009_1.jpg GRAPHIC 44577
3 OMP LOGO obagilogo.jpg GRAPHIC 5764
4 STEVE CARLSON AGREEMENT 1ST AMENDMENT stevecexhibit.htm EX-10.11 14908
5 STEVE CARLSON AGREEMENT 3RD AMENDMENT exhibit1027.htm EX-10.27 23308
6 2009 INCENTIVE PLAN exhibit1034.htm EX-10.34 67909
7 DDN 3PL exhibit1035.htm EX-10.35 101349
8 STEVE CARLSON AGREEMENT 4TH AMENDMENT exhibit1036.htm EX-10.36 13709
9 CONSENT LETTER exhibit231.htm EX-23.1 3928
10 SECTION 302 CERIFICATION, STEVE CARLSON exhibit311.htm EX-31.1 14235
11 SECTION 302 CERIFICATION, PRESTON ROMM exhibit312.htm EX-31.2 14002
12 SECTION 906 CERTIFICATION, STEVE CARLSON exhibit321.htm EX-32.1 8438
13 SECTION 906 CERTIFICATION, PRESTON ROMM exhibit322p.htm EX-32.2 8387
  Complete submission text file 0001375247-10-000007.txt   2405723
Mailing Address 310 GOLDEN SHORE LONG BEACH CA 90802
Business Address 310 GOLDEN SHORE LONG BEACH CA 90802 562-628-1007
Obagi Medical Products, Inc. (Filer) CIK: 0001375247 (see all company filings)

EIN.: 954658730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33204 | Film No.: 10679457
SIC: 2834 Pharmaceutical Preparations